Ticker: ACIU

08:22am, Thursday, Dec 11, 2025

AC Immune Shares Surge 25% Following Bright Interim Parkinson's Trial Results

AC Immune (NASDAQ:ACIU) stock jumped 25% after positive Phase 2 data suggested its Parkinson's treatment might slow disease progression, showing stable biomarkers and good safety.